| ADAM-10 | A disintegrin and metalloproteinase domain containing protein-10 |
| ALDH-1 | Aldehyde dehydrogenase-1 |
| APCs | Antigen presenting cells |
| BC | Breast cancer |
| BCSCs | Breast cancer stem cells |
| CM | Conditioned medium |
| CSCs | Cancer stem cell-like cells |
| DAB | 3,3′-Diaminobenzidine |
| DAPI | 4′,6-Diamidine-2′-phenylindole dihydrochloride |
| ECL | Enhanced chemiluminescence |
| EMT | Epithelial–mesenchymal transition |
| ESM-1 | Endothelial cell specific molecule-1 |
| HER2 | Human epidermal growth factor receptor 2 |
| HIF-1α | Hypoxia-inducible factor-1α |
| HLA-E | HLA class I molecules-E |
| HRP | Horseradish peroxidase |
| IHC | Immunohistochemistry |
| LDH | Lactate dehydrogenase |
| LOX | Lysyl oxidase |
| MDSC | Myeloid-derived suppressor cells |
| MICA/B | MHC class I chain-related molecules A/B |
| NK cells | Natural killer cells |
| NLR | Neutrophil-to-lymphocyte ratio |
| NP-40 | Nonylphonoxypolyethoxypthanol-40 |
| ROS | Reactive oxygen species |
| RT | Radiotherapy |
| RT-R | Radiotherapy-resistant |
| RT-PCR | Reverse transcription-polymerase chain reaction |
| SDS-PAGE | Sodium dodecyl sulfate- polyacrylamide gel electrophoresis |
| TAMs | Tumor-associated macrophages |
| TME | Tumor microenvironment |
| TNBC | Triple-negative breast cancer |
| Tregs | Regulatory T cells |